AstraZeneca's Blockbuster Cancer Drug Imfinzi Flunks As Follow-Up In Type Of Early-Stage ...

Retrieved on: 2024-06-25 20:01:07

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca's Blockbuster Cancer Drug Imfinzi Flunks As Follow-Up In Type Of Early-Stage .... View article details on hiswai:

Excerpt

On Tuesday, AstraZeneca Plc (NASDAQ:AZN) released topline data from the ADJUVANT BR.31 Phase 3 trial, sponsored by the Canadian Cancer Trials ...

Article found on: finance.yahoo.com